An analysis of self-funded plans by one of our partners showed that if a 250-person company chooses to cover GLP-1s for weight loss, even assuming a lifetime maximum of $18,000, they can expect to see a total claims increase of 5%
Its also the target of popular weight loss medications like Ozempic and Wegovy
A popular dual agonist, tirzepatide (Mounjaro), activates both GLP-1R and GIPR, producing synergistic effects on insulin secretion, appetite suppression, and weight reduction (Table 1)
You dont need to enjoy it, you just need to do it
Short-chain fatty acids (SCFAs) produced by gut bacteria through activation of the G protein-coupled free fatty acid receptors FFAR2 (GPR43) and FFAR3 (GPR41) induce GLP-1 Secretion [159]
The prevalence of GLP-1 use has become so significant that it is critical we address how to manage the associated skin-related effects